{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:12:19Z","timestamp":1790662339675,"version":"4.1.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:00:00Z","timestamp":1571097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02412","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T04:15:29Z","timestamp":1571112929000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["A Viral-Vectored Multi-Stage Malaria Vaccine Regimen With Protective and Transmission-Blocking Efficacies"],"prefix":"10.3389","volume":"10","author":[{"given":"Yenni","family":"Yusuf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Yoshii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Iyori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke S.","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha Bin","family":"Emran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fitri","family":"Amelia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashekul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Intan","family":"Syafira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,15]]},"reference":[{"key":"B1","first-page":"11","article-title":"Biology of malaria parasites","volume-title":"Malaria Parasites","author":"Igweh","year":"2012"},{"key":"B2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0169-4758(97)01040-5","article-title":"Multi-gene vaccination against malaria: a multistage, multi-immune response approach","volume":"13","author":"Doolan","year":"1997","journal-title":"Parasitol Today."},{"key":"B3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2174\/156652406776055249","article-title":"Immune responses to pre-erythrocytic stages of malaria parasites","volume":"6","author":"Doolan","year":"2006","journal-title":"Curr Mol Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e61395","DOI":"10.1371\/journal.pone.0061395","article-title":"The Relationship between RTS,S vaccine-induced antibodies, CD4+ T cell responses and protection against Plasmodium falciparum infection","volume":"8","author":"White","year":"2013","journal-title":"PLoS ONE."},{"key":"B5","doi-asserted-by":"publisher","first-page":"7538","DOI":"10.1016\/j.vaccine.2015.09.111","article-title":"Building an effective malaria vaccine pipeline to address global needs","volume":"33","author":"Birkett","year":"2015","journal-title":"Vaccine."},{"key":"B6","unstructured":"Malaria Vaccine Rainbow Tables."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/S0140-6736(13)62238-2","article-title":"Malaria vaccine technology roadmap","volume":"382","author":"Moorthy","year":"2013","journal-title":"Lancet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"B233","DOI":"10.1016\/j.vaccine.2013.02.040","article-title":"Malaria vaccine R&D in the decade of vaccines: breakthroughs, challenges and opportunities","volume":"31","author":"Birkett","year":"2013","journal-title":"Vaccine."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e35213","DOI":"10.7554\/eLife.35213","article-title":"Synergy in anti-malarial pre-erythrocytic and transmission-blocking antibodies is achieved by reducing parasite density","volume":"7","author":"Sherrard-Smith","year":"2018","journal-title":"Elife."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.4049\/jimmunol.1003783","article-title":"Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference","volume":"187","author":"Forbes","year":"2011","journal-title":"J Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1038\/mt.2012.223","article-title":"ChAd63-MVA\u2013vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans","volume":"20","author":"Sheehy","year":"2012","journal-title":"Mol Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e24586","DOI":"10.1371\/journal.pone.0024586","article-title":"Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adults","volume":"6","author":"Sedegah","year":"2011","journal-title":"PLoS ONE."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e25868","DOI":"10.1371\/journal.pone.0025868","article-title":"Adenovirus-5-Vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component","volume":"6","author":"Tamminga","year":"2011","journal-title":"PLoS ONE."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e55571","DOI":"10.1371\/journal.pone.0055571","article-title":"DNA prime\/adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity","volume":"8","author":"Chuang","year":"2013","journal-title":"PLoS ONE."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.3389\/fimmu.2018.02780","article-title":"Combination of RTS,S and Pfs25-IMX313 induces a functional antibody response against malaria infection and transmission in mice","volume":"9","author":"Brod","year":"2018","journal-title":"Front Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"7514","DOI":"10.1016\/j.vaccine.2011.03.083","article-title":"A human Phase I\/IIa malaria challenge trial of a polyprotein malaria vaccine","volume":"29","author":"Porter","year":"2011","journal-title":"Vaccine."},{"key":"B17","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1128\/IAI.64.9.3833-3844.1996","article-title":"NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria","volume":"64","author":"Tine","year":"1996","journal-title":"Infect Immun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1086\/515331","article-title":"Phase I\/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria","volume":"177","author":"Ockenhouse","year":"1998","journal-title":"J Infect Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/biot.201500055","article-title":"The stage-specific in vitro efficacy of a malaria antigen cocktail provides valuable insights into the development of effective multi-stage vaccines","volume":"10","author":"Spiegel","year":"2015","journal-title":"Biotechnol J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"7444","DOI":"10.1016\/j.vaccine.2015.09.094","article-title":"Progress with viral vectored malaria vaccines: a multi-stage approach involving \u201cunnatural immunity\u201d","volume":"33","author":"Ewer","year":"2015","journal-title":"Vaccine."},{"key":"B21","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3389\/fimmu.2019.00730","article-title":"Adeno-associated virus as an effective malaria booster vaccine following adenovirus priming","volume":"10","author":"Yusuf","year":"2019","journal-title":"Front Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e29428","DOI":"10.1371\/journal.pone.0029428","article-title":"A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity","volume":"6","author":"Goodman","year":"2011","journal-title":"PLoS ONE."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e12498","DOI":"10.1111\/pim.12498","article-title":"Protective efficacy of an IL-12-expressing baculoviral malaria vaccine","volume":"39","author":"Iyori","year":"2017","journal-title":"Parasite Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1038\/s41598-018-21369-y","article-title":"Adenovirus-prime and baculovirus-boost heterologous immunization achieves sterile protection against malaria sporozoite challenge in a murine model","volume":"8","author":"Yoshida","year":"2018","journal-title":"Sci Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"11899","DOI":"10.1128\/JVI.00890-06","article-title":"Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells","volume":"80","author":"Xin","year":"2006","journal-title":"J Virol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1128\/IAI.01056-13","article-title":"Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay","volume":"81","author":"Miura","year":"2013","journal-title":"Infect Immun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1101\/320036","article-title":"Baculovirus-induced fast-acting innate immunity kills liver-stage Plasmodium","volume":"201","author":"Emran","year":"2018","journal-title":"J Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1126\/science.1211548","article-title":"Live attenuated malaria vaccine designed to protect through hepatic CD8 T cell immunity","volume":"334","author":"Epstein","year":"2011","journal-title":"Science."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1016\/j.vaccine.2016.06.066","article-title":"Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay","volume":"34","author":"Miura","year":"2016","journal-title":"Vaccine."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/s41467-017-01924-3","article-title":"Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25","volume":"8","author":"Scally","year":"2017","journal-title":"Nat Commun."},{"key":"B31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1475-2875-9-145","article-title":"Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy","volume":"9","author":"Leitner","year":"2010","journal-title":"Malaria J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1475-2875-6-107","article-title":"Transmission-blocking activity induced by malaria vaccine candidates Pfs25\/Pvs25 is a direct and predictable function of antibody titer","volume":"6","author":"Miura","year":"2007","journal-title":"Malar J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1126\/science.1184785","article-title":"That was then but this is now: malaria research in the time of an eradication agenda","volume":"328","author":"Kappe","year":"2010","journal-title":"Science."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.3389\/fimmu.2017.01998","article-title":"Assessment of antibodies induced by multivalent transmission-blocking malaria vaccines","volume":"8","author":"Menon","year":"2018","journal-title":"Front Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1515257","article-title":"Seven-year efficacy of RTS,S\/AS01 malaria vaccine among young African children","volume":"374","author":"Olotu","year":"2016","journal-title":"N Engl J Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","year":"2015","journal-title":"Lancet."},{"key":"B37","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1042\/ETLS20170117","article-title":"A whole parasite transmission-blocking vaccine for malaria: an ignored strategy","volume":"1","author":"Good","year":"2017","journal-title":"Emerg Top Life Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e2636","DOI":"10.1371\/journal.pone.0002636","article-title":"Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51","volume":"3","author":"Wu","year":"2008","journal-title":"PLoS ONE."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1017\/S0031182008000280","article-title":"Efficacy model for mosquito stage transmission blocking vaccines for malaria","volume":"135","author":"Saul","year":"2008","journal-title":"Parasitology."},{"key":"B40","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/414751a","article-title":"Imperfect vaccines and the evolution of pathogen virulence","volume":"414","author":"Gandon","year":"2001","journal-title":"Nature."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.4049\/jimmunol.1201455","article-title":"Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infection","volume":"190","author":"Elias","year":"2013","journal-title":"J Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3389\/fimmu.2018.01660","article-title":"CXCR3(+) T follicular helper cells induced by co-administration of RTS,S\/AS01B and viral-vectored vaccines are associated with reduced immunogenicity and efficacy against malaria","volume":"9","author":"Bowyer","year":"2018","journal-title":"Front Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1073\/pnas.0913374107","article-title":"A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates","volume":"107","author":"Kubler-Kielb","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"B44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.chom.2018.06.008","article-title":"Malaria vaccines: recent advances and new horizons","volume":"24","author":"Draper","year":"2018","journal-title":"Cell Host Microbe."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02412\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T20:52:06Z","timestamp":1611521526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02412\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,15]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2019.02412"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02412","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,15]]},"article-number":"2412"}}